Lexicon Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Abbott USD 6.53B 1.08B 2025-03
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
AstraZeneca USD 5.23B 258M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Illumina USD 1.11B 14M 2025-03
Insmed USD 403.25M 151.78M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
J&J USD 38.47B 32.35B 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
MannKind USD 47.31M 973K 2025-03
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Novartis USD 8.87B 4.74B 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Thermo Fisher Scientific USD 4.13B 125M 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03



Lexicon Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.